Literature DB >> 19275493

Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura.

Melody Benjamin1, Deirdra R Terrell, Sara K Vesely, Gene W Voskuhl, Bruce J Dezube, Johanna A Kremer Hovinga, Bernhard Lämmle, James N George.   

Abstract

BACKGROUND: Case series of patients with a diagnosis of thrombotic thrombocytopenic purpura (TTP) have reported different frequencies of human immunodeficiency virus (HIV) infection; some series suggest that HIV infection may cause TTP.
METHODS: We systematically reviewed all reports of HIV infection in case series of patients with TTP. We analyzed data from the Oklahoma TTP-HUS (hemolytic uremic syndrome) Registry, an inception cohort of 362 consecutive patients, for 1989-2007.
RESULTS: Nineteen case series reported the occurrence of HIV infection at the time of diagnosis of TTP in 0%-83% of patients; individual patient data were rarely described. The Oklahoma TTP-HUS Registry determined the HIV status at the time of diagnosis of TTP in 351 (97%) of 362 patients. HIV infection was documented in 6 (1.84%; 95% CI, 0.68%-4.01%) of 326 adult patients (age, 26-51 years); follow-up data were complete for all 6 patients. The period prevalence of HIV infection among all adults in the Oklahoma TTP-HUS Registry region for 1989-2007 was 0.30%. One patient had typical features of TTP with 5 relapses. Five patients had single episodes; in 4, the clinical features that had initially suggested the diagnosis of TTP were subsequently attributed to malignant hypertension (in 3 patients) and disseminated Kaposi sarcoma (in 1 patient).
CONCLUSIONS: HIV infection, similar to other inflammatory conditions, may trigger acute episodes of TTP in susceptible patients. More commonly, acquired immunodeficiency syndrome-related disorders may mimic the clinical features of TTP. If the diagnosis of TTP is suggested in a patient with HIV infection, there should be careful evaluation for alternative diagnoses and cautious consideration of plasma exchange, the required treatment for TTP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275493     DOI: 10.1086/597471

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  46-year-old man with fatigue and brown urine.

Authors:  Michael A Mao; John R Hoyt; Mark A Nyman
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

2.  Systemic infections mimicking thrombotic thrombocytopenic purpura.

Authors:  Kristina K Booth; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

3.  Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura.

Authors:  Rahel Froehlich-Zahnd; James N George; Sara K Vesely; Deirdra R Terrell; Khatira Aboulfatova; Jing-Fei Dong; Brenda M Luken; Jan Voorberg; Ulrich Budde; Irmela Sulzer; Bernhard Lämmle; Johanna A Kremer Hovinga
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

Review 4.  Flavorubredoxin, a Candidate Trigger Related to Thrombotic Thrombocytopenic Purpura: Screening of the Complete Genome of a Salmonella enterica Serovar Typhimurium Isolate From an AIDS Case.

Authors:  Zhouhan Wang; Hao Xu; Beiqing Gu; Yanqi Jin; Tianyuan Wang; Jindi Ma; Yingfeng Lu; Xiaopeng Yu; Beiwen Zheng; Yimin Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-06-10       Impact factor: 6.073

5.  Thrombotic microangiopathy and human immunodeficiency virus in the era of eculizumab.

Authors:  Anna Jin; Laleh Boroujerdi-Rad; Gaurang Shah; Joline L T Chen
Journal:  Clin Kidney J       Date:  2016-05-17

6.  Thrombotic thrombocytopenic purpura (TTP)-like syndrome in the HIV era.

Authors:  Susan Louw; Reenelle Gounden; Elizabeth Sarah Mayne
Journal:  Thromb J       Date:  2018-12-13

Review 7.  Thrombotic microangiopathy as first manifestation of acute human immunodeficiency virus infection: a case report and review of the literature.

Authors:  M Sarmiento; M E Balcells; P Ramirez
Journal:  J Med Case Rep       Date:  2016-06-07

8.  Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa.

Authors:  Elizabeth S Mayne; Anthony L H Mayne; Susan J Louw
Journal:  PLoS One       Date:  2018-04-12       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.